445 related articles for article (PubMed ID: 26947962)
1. Outcomes of pelvic exenteration for locally advanced primary rectal cancer: Overall survival and quality of life.
Quyn AJ; Austin KK; Young JM; Badgery-Parker T; Masya LM; Roberts R; Solomon MJ
Eur J Surg Oncol; 2016 Jun; 42(6):823-8. PubMed ID: 26947962
[TBL] [Abstract][Full Text] [Related]
2. Quality of life of survivors after pelvic exenteration for rectal cancer.
Austin KK; Young JM; Solomon MJ
Dis Colon Rectum; 2010 Aug; 53(8):1121-6. PubMed ID: 20628274
[TBL] [Abstract][Full Text] [Related]
3. Baseline quality of life predicts pelvic exenteration outcome.
Choy I; Young JM; Badgery-Parker T; Masya LM; Shepherd HL; Koh C; Heriot AG; Solomon MJ
ANZ J Surg; 2017 Nov; 87(11):935-939. PubMed ID: 26687437
[TBL] [Abstract][Full Text] [Related]
4. Quality of life and other patient-reported outcomes following exenteration for pelvic malignancy.
Young JM; Badgery-Parker T; Masya LM; King M; Koh C; Lynch AC; Heriot AG; Solomon MJ
Br J Surg; 2014 Feb; 101(3):277-87. PubMed ID: 24420909
[TBL] [Abstract][Full Text] [Related]
5. A systematic review examining quality of life following pelvic exenteration for locally advanced and recurrent rectal cancer.
Rausa E; Kelly ME; Bonavina L; O'Connell PR; Winter DC
Colorectal Dis; 2017 May; 19(5):430-436. PubMed ID: 28267255
[TBL] [Abstract][Full Text] [Related]
6. Palliative Pelvic Exenteration: Clinical Outcomes and Quality of Life.
Quyn AJ; Solomon MJ; Lee PM; Badgery-Parker T; Masya LM; Young JM
Dis Colon Rectum; 2016 Nov; 59(11):1005-1010. PubMed ID: 27749474
[TBL] [Abstract][Full Text] [Related]
7. Determinants of survival following pelvic exenteration for primary rectal cancer.
Radwan RW; Jones HG; Rawat N; Davies M; Evans MD; Harris DA; Beynon J;
Br J Surg; 2015 Sep; 102(10):1278-84. PubMed ID: 26095525
[TBL] [Abstract][Full Text] [Related]
8. Quality-of-life outcomes following pelvic exenteration for primary rectal cancer.
Radwan RW; Codd RJ; Wright M; Fitzsimmons D; Evans MD; Davies M; Harris DA; Beynon J
Br J Surg; 2015 Nov; 102(12):1574-80. PubMed ID: 26373700
[TBL] [Abstract][Full Text] [Related]
9. [Quality of life after extensive pelvic surgery].
Levý M; Lipská L; Visokai V; Šimša J
Rozhl Chir; 2016; 95(9):358-462. PubMed ID: 27653304
[TBL] [Abstract][Full Text] [Related]
10. Pelvic exenteration for men with locally advanced rectal cancer: a morbidity analysis of complicated cases.
Hsu TW; Chiang FF; Chen MC; Wang HM
Asian J Surg; 2011 Jul; 34(3):115-20. PubMed ID: 22208686
[TBL] [Abstract][Full Text] [Related]
11. Total pelvic exenteration for primary and recurrent malignancies.
Ferenschild FT; Vermaas M; Verhoef C; Ansink AC; Kirkels WJ; Eggermont AM; de Wilt JH
World J Surg; 2009 Jul; 33(7):1502-8. PubMed ID: 19421811
[TBL] [Abstract][Full Text] [Related]
12. Cystoprostatectomy versus prostatectomy alone for locally advanced or recurrent pelvic cancer.
Turner GA; Harris CA; Eglinton TW; Wakeman CJ; Kueppers F; Dixon L; Dobbs BR; Frizelle FA
ANZ J Surg; 2016; 86(1-2):54-8. PubMed ID: 25113257
[TBL] [Abstract][Full Text] [Related]
13. Outcomes of pelvic exenteration for recurrent and primary locally advanced rectal cancer.
Rottoli M; Vallicelli C; Boschi L; Poggioli G
Int J Surg; 2017 Dec; 48():69-73. PubMed ID: 28987560
[TBL] [Abstract][Full Text] [Related]
14. Robotic pelvic exenteration and extended pelvic resections for locally advanced or synchronous rectal and urological malignancy.
Williams M; Perera M; Nouhaud FX; Coughlin G
Investig Clin Urol; 2021 Jan; 62(1):111-120. PubMed ID: 33381928
[TBL] [Abstract][Full Text] [Related]
15. Total pelvic exenteration for primary locally advanced and locally recurrent rectal cancer.
Vermaas M; Ferenschild FT; Verhoef C; Nuyttens JJ; Marinelli AW; Wiggers T; Kirkels WJ; Eggermont AM; de Wilt JH
Eur J Surg Oncol; 2007 May; 33(4):452-8. PubMed ID: 17071043
[TBL] [Abstract][Full Text] [Related]
16. Social deprivation in patients requiring pelvic exenterative surgery.
Radwan RW; Coyne PE; Jones HG; Evans MD; Davies M; Harris DA; Beynon J
Colorectal Dis; 2016 Jul; 18(7):684-7. PubMed ID: 26773422
[TBL] [Abstract][Full Text] [Related]
17. Role of pelvic exenteration in the management of locally advanced primary and recurrent rectal cancer.
Xin KY; Ng DW; Tan GH; Teo MC
J Gastrointest Cancer; 2014 Sep; 45(3):291-7. PubMed ID: 24563189
[TBL] [Abstract][Full Text] [Related]
18. Indications and outcome of pelvic exenteration for locally advanced primary and recurrent rectal cancer.
Bhangu A; Ali SM; Brown G; Nicholls RJ; Tekkis P
Ann Surg; 2014 Feb; 259(2):315-22. PubMed ID: 23478530
[TBL] [Abstract][Full Text] [Related]
19. [Urinary complications of pelvic exenterations for rectal cancer with urinary invasion].
Gas J; Beauval JB; Chalret du Rieu M; Bou Nasr E; Philis A; Kirzin S; Thoulouzan M; Soulié M; Ghouti L
Prog Urol; 2015 May; 25(6):348-54. PubMed ID: 25804429
[TBL] [Abstract][Full Text] [Related]
20. Sacral resection with pelvic exenteration for advanced primary and recurrent pelvic cancer: a single-institution experience of 100 sacrectomies.
Milne T; Solomon MJ; Lee P; Young JM; Stalley P; Harrison JD; Austin KK
Dis Colon Rectum; 2014 Oct; 57(10):1153-61. PubMed ID: 25203370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
